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In 1997, a locus for benign familial infantile convulsions (BFIC) was mapped to chromosome 19q. Further data
suggested that this locus is not involved in all families with BFIC. In the present report, we studied eight Italian
families and mapped a novel BFIC locus within a 0.7-cM interval of chromosome 2q24, between markers D2S399
and D2S2330. A maximum multipoint HLOD score of 6.29 was obtained under the hypothesis of genetic heter-
ogeneity. Furthermore, the clustering of chromosome 2q24–linked families in southern Italy may indicate a recent
founder effect. In our series, 40% of the families are linked to neither chromosome 19q or 2q loci, suggesting that
at least three loci are involved in BFIC. This finding is consistent with other autosomal dominant idiopathic epilepsies
in which different genes were found to be implicated.
Benign familial infantile convulsions (BFIC [MIM
601764]) is an epileptic phenotype that recently has been
recognized as a distinct syndrome segregating as an au-
tosomal dominant trait (Vigevano et al. 1992). Clinical
features of BFIC include partial seizures, occurring in
clusters lasting over a 2–4-d period, between the ages of
4 and 11 mo. Seizures are characterized by psychomotor
arrest, slow deviation of the head and eyes to one side,
and asynchronous limb jerks. Ictal EEG shows dis-
charges arising from central-occipital regions and then
Received January 24, 2001; accepted for publication March 22,
2001; electronically published April 20, 2001.
Address for correspondence and reprints: Dr. Federico Zara, La-
boratorio di Genetica Umana, E.O. Ospedali Galliera, Via Volta 10r,
16128 Genova, Italy. E-mail: f.zara@galliera.it
* These authors equally contributed to this work.
 2001 by The American Society of Human Genetics. All rights reserved.
0002-9297/2001/6806-0025$02.00
spreading over the entire brain. Interictal EEG is normal,
and no metabolic disorders or brain lesions are observed
(Vigevano et al. 1992). Clinically, this disorder is quite
homogeneous, and age at onset, features, frequency, and
the benign course of partial seizures are very similar
among patients from different families.
In 1997, a locus for BFIC was mapped on chromo-
some 19q, between markers D19S49 and D19S245, by
a study of five families of Italian descent (Guipponi et
al. 1997). In the same year, Szepetowski et al. (1997)
described a related autosomal dominant phenotype
(ICCA [MIM 602066] showing benign infantile con-
vulsions associated with paroxysmal choreoathetosis.
Mapping of the gene to chromosome 16p demonstrated
that BFIC and ICCA are not allelic to the same gene.
Recently, we have further investigated the role of the
chromosome 19q BFIC locus by studying a new set of
Italian families affected with BFIC. Since no evidence of
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Table 1
Family-Specific Multipoint LOD Scores for Markers on Chromosomes 2q and 19q
MARKER
DISTANCE FROM
PREVIOUS MARKER
(cM)
MULTIPOINT LOD FOR FAMILY
1 2 3 4 5 6 7 8
D2S156 … 3.7721 1.3126 1.2314 1.7773 2.5455 .6492 1.4839 .4768
D2S2395 1.3 3.7820 1.0968 1.2351 1.7173 2.7421 1.2267 1.4972 .4768
D2S2380 .1 3.7828 1.1050 1.2354 1.4664 2.7668 1.3870 1.4972 .4768
D2S399 1.9 3.7832 1.1339 1.2387 .7206 1.5462 1.3813 1.4972 .4768
D2S111 .2 3.7836 1.1343 1.2417 2.2855 1.5364 1.3904 1.4972 .4768
D2S2157 .1 3.7836 1.1343 1.2428 2.3079 1.5236 1.3905 1.4972 .4768
D2S2195 .1 3.7836 1.1343 1.2428 2.3106 1.5055 1.3905 1.4972 .4768
D2S2384 .1 3.7836 1.1343 1.1271 2.3113 1.4953 1.3906 1.4972 .4768
D2S124 .1 3.4821 1.1343 1.1094 2.3114 1.4873 1.2597 1.4972 .4768
D2S2330 .1 7.5200 1.1325 1.1021 2.3113 .1796 1.2058 1.4972 .4768
D19S414 … 7.0732 .3647 .5417 1.1035 2.5564 1.4508 1.4972 .4768
D19S868 2.7 7.8131 .3265 .6857 3.4402 3.1953 1.4530 1.4972 .4768
D19S416 2.2 7.7989 .3488 .6863 2.9683 3.1155 1.4341 1.4972 .4768
D19S425 .6 7.8131 .2764 .6607 1.6626 3.1103 1.4265 1.4972 .4768
NOTE.—Genetic distances were deduced from the Ge´ne´thon linkage map (Dib et al. 1996).
linkage was found, we have hypothesized genetic het-
erogeneity (Gennaro et al. 1999).
To identify new BFIC loci, we have performed a ge-
nomewide search by studying a large Italian kindred, as
described by Giordano et al. (1999) (fig. 1). Since sei-
zures disappear after age 1 year, leaving no clinical sign
of the disease, and diagnosis in adult individuals can be
established only on the basis of anamnestic data, we have
focused our analysis on those family branches segregat-
ing the disease to individuals for whom complete clinical
documentation was available (fig. 1; family 1, genera-
tions III and IV, ages 18 mo to 25 years).
Three hundred eighty-eight fluorescence-labeled mar-
kers of the ABI Prism linkage-mapping set, version 2 (PE
Biosystems), were typed by PCR, and genotypes were an-
alyzed by GENESCAN 2.0 and GENOTYPER 3.0 soft-
ware on a 377 ABI Prism genetic analyzer. Parametric
two-point linkage analysis was performed using the
LINKAGE 5.1 package (Lathrop et al. 1985) in the FAS-
TLINK 4.0 implementation (Cottingham et al. 1993).
LOD scores were calculated under the assumption of a
fully penetrant dominant trait with a prevalence of .001
and a phenocopy rate of .05. Equifrequent marker alleles
were used throughout the analysis.
Preliminary evidence of linkage was found for marker
D2S2330 (maximum pairwise LOD score 1.67 at vp
; data not shown). Therefore, we typed additional.1
markers from the Ge´ne´thon linkage map (Dib et al.
1996) and performed multipoint parametric linkage
analysis using the ALLEGRO 1.1 software (Gudbjarrts-
son et al. 2000). A maximum multipoint LOD score of
3.78 was obtained between markers D2S111 and
D2S2384 (table 1). Furthermore, we have extended our
analysis to seven additional families affected with BFIC
(families 5, 6, 7, and 8 were described in Gennaro et al.
(1999); families 2, 3, and 4 are previously unpublished)
(fig. 1).
Linkage to chromosome 2q was consistent for families
2, 3, and 4 and was excluded for families 5, 6, 7, and
8 (table 1). A maximum cumulative multipoint LOD
score of 3.60 was obtained for marker D2S2195. When
locus heterogeneity was allowed, the multipoint HLOD
score rose to 6.29 with 47% of linked families (data not
shown).
To exclude the involvement of the chromosome 19q
BFIC locus, we have typed families 2, 3, and 4 with mark-
ers D19S414, D19S868, D19S416, and D19S425 (gen-
otypes not shown). Parametric multipoint linkage analysis
provided further evidence that the chromosome 19q is
not a major locus for BFIC (table 1). So far, in our sample,
only family 7 shows evidence (weak evidence) of linkage
to chromosome 19q.
To further investigate genetic heterogeneity, we have
performed the admixture test implemented in the
HOMOG program (Ott 1991) by using chromosome 2q
multipoint LOD scores. Significant evidence for genetic
heterogeneity was obtained (table 2). No evidence for
three-locus genetic heterogeneity was found when
chromosome 19 data were added to the analysis
(HOMOG3R), because of the lack of linkage to chro-
mosome 19q locus in our family sample.
The analysis of haplotypes showed recombinations in
an ancestral chromosome (individual III-6, family 4),
between markers D2S399 and D2S111, and a key re-
combination, between marker D2S2384 and D2S2330,
in family 1, individual III-1 (fig. 1). The BFIC locus there-
fore must lie within a 0.7-cM interval on chromosome
2q24. Moreover, a key recombination further narrowing
the critical region to 0.4 cM could have occurred in
individual III-1, family 3, between markers D2S2195
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Table 2
HOMOG Analysis of Multipoint Data
Hypothesesa df x2
Likelihood
Ratio
H2 vs. H1 1 10.35 176.73
H1 vs. H0 1 18.64 1.12#104
H2 vs. H0 2 28.99 1.97#106
a H0 p no linkage; H1 p linkage and
homogeneity; H2 p linkage and hetero-
geneity.
Figure 2 Geographical distribution of BFIC families. Linked
families are indicated with underlined numbers.
and D2S2384. However, since parental genotypes are
not available and the heterozygosity state of flanking
marker(s) could not be determined, this crossover can
not be precisely localized (fig. 1).
In our series, about half of the families should be
associated with the chromosome 2q locus, and other
genes are likely involved in the etiology of BFIC. Analysis
of the geographical origins of our BFIC families (as far
back as the 19th century) indicates that families are clus-
tered in definite areas, suggesting possible founder effects
(fig. 2); families linked to chromosome 2q24 are clus-
tered in southern Italy, and unlinked families are clus-
tered in northeastern Italy. To date, no evidence for a
shared ancestral haplotype was found in our family sam-
ple (fig. 1). It has been shown, however, that linkage
disequilibrium may extend to only a few kb from mu-
tated alleles, depending on the age of mutations and the
demographic history of populations (Kruglyak 1999).
The development of a physical map of the region and
the identification of a several closely spaced markers will
therefore be necessary to detect linkage disequilibrium.
Therefore, we have performed a detailed analysis of clin-
ical data, to identify possible clinical subsets underlying
genetic heterogeneity. No significant phenotypic differ-
ences have been found among families. Our data fit well
the emerging scenario of autosomal dominant idiopathic
epilepsies.
In autosomal dominant nocturnal frontal lobe epi-
lepsy (ADNFLE [MIM 600513, 603204, and 605375]),
two neuronal acetylcholine receptor subunit genes—
CHRNA4 on chromosome 20q (Steinlein et al. 1995)
and CHRNB2 on chromosome 1q (De Fusco et al.
2000)—were found to be mutated, and a third locus has
been mapped to chromosome 15q (Phillips et al. 1998).
In benign familial neonatal convulsions (BFNC [MIM
121200 and 121201]) mutations in two different neu-
ronal voltage-gated potassium channel genes (KCNQ2
and KCNQ3) were identified (Charlier et al. 1998; Singh
et al. 1998). Similarly, two neuronal voltage-gated so-
dium channel subunit genes, SCN1B and SCN1A, were
associated to generalized idiopathic epilepsy and febrile
convulsions in GEFS families (GEFS [MIM 604236
and 604233]; Wallace et al. 1998; Escayg et al. 2000).
The involvement of neuronal ion-channel subunits
and genetic heterogeneity appear so far the most rep-
resentative traits of autosomal dominant idiopathic ep-
ilepsies. In BFIC, the presence of features common to
the above-mentioned epilepsies—such as the benign out-
come of the seizures and the autosomal dominant pat-
tern of inheritance—suggests that ion-channel genes
could be also involved. Genetic heterogeneity would also
support this hypothesis, since ion-channel genes are
highly redundant in the human genome. According to
this assumption, the 0.7-cM critical region on chro-
mosome 2q could harbor four potential candidate genes
for BFIC: SCN1A, SCN2A, SCN3A, and KCNJ3.
SCN1A, SCN2A, and SCN3A are highly expressed in
brain and form a sodium-channel a-subunit gene cluster
mapped on chromosome 2q23-24. Since SCN1A re-
cently was demonstrated to be associated with gener-
alized epilepsy and febrile convulsions (Escayg et al.
2000), the detection of mutations in families affected
with BFIC would demonstrate that GEFS and BFIC
are allelic to the same gene. Interestingly, a similar as-
sociation is found on chromosome 19q, where the BFIC
locus was mapped to the same chromosomal region har-
boring the GEFS gene, SCN1B (Wallace et al. 1998).
A recent study, however, failed to detect mutations at
SCN1B in families linked to the chromosome 19 BFIC
locus (Moulard et al. 2000). In contrast, SCN2A and
SCN3A have not yet been associated with human
phenotypes.
KCNJ3 encodes a G-protein-coupled potassium in-
wardly rectifying channel that is thought to be involved
in receptor-mediated inhibitory postsynaptic potentials
(Kubo et al. 1993; Chen and Yu 1994). KCNJ3 is a
potential candidate for BFIC for at least two reasons:
first, the reduction of inward K current in neurons,
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caused by mutations in voltage-gated potassium chan-
nels, was associated with BFNC, a syndrome that is
closely related to BFIC (Charlier et al. 1998; Singh et
al. 1998); second, a mouse model of epilepsy—
weaver—is associated with mutations in the related gene
KCNJ6 (Patil et al. 1995). In brain, KCNJ3 channels
are functionally activated through the formation of het-
erotetrameric complexes with KCNJ6 (Duprat at al.
1995). Thus, we can assume that KCNJ3 mutations af-
fecting the same complex may underlie seizures in hu-
mans too.
In summary, we have identify a second locus for BFIC
on chromosome 2q24 and have provided evidence for
genetic heterogeneity, suggesting the presence of differ-
ent genes involved in the etiology of BFIC. The identi-
fication of the mutated gene will either provide further
evidence of the primary role of neuronal ion-channel
genes in the etiology of idiopathic epilepsy or will lead
to the identification of new epileptogenic mechanisms.
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